Paxil CR 25mg Tablets

Manufacturer APOTEX Active Ingredient Paroxetine Controlled-Release Tablets(pa ROKS e teen) Pronunciation PAX-il SEE-AR (for brand); pa-ROKS-e-teen (for active ingredient)
WARNING: Drugs like this one have raised the chance of suicidal thoughts or actions in children and young adults. The risk may be greater in people who have had these thoughts or actions in the past. All people who take this drug need to be watched closely. Call the doctor right away if signs like depression, nervousness, restlessness, grouchiness, panic attacks, or changes in mood or actions are new or worse. Call the doctor right away if any thoughts or actions of suicide occur.This drug is not approved for use in children. Talk with the doctor. @ COMMON USES: It is used to treat depression.It is used to treat panic attacks.It is used to treat anxiety.It is used to treat mood problems caused by monthly periods.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Antidepressant
đŸ§Ŧ
Pharmacologic Class
Selective Serotonin Reuptake Inhibitor (SSRI)
🤰
Pregnancy Category
Category D
✅
FDA Approved
Jun 1999
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Paxil CR is a medication used to treat depression, panic attacks, and a severe form of PMS called PMDD. It works by helping to restore the balance of a natural substance in the brain called serotonin. This medication is a controlled-release tablet, meaning it releases the medicine slowly over time.
📋

How to Use This Medicine

Taking Your Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. Take your medication as directed, with or without food, and continue taking it even if you feel well. Swallow the medication whole; do not chew, break, or crush it. Unless your doctor advises otherwise, take your medication in the morning.

Storing and Disposing of Your Medication

Store your medication at room temperature in a dry place, avoiding the bathroom. Keep all medications in a safe location, out of the reach of children and pets. Dispose of unused or expired medications properly. Do not flush them down the toilet or pour them down the drain unless instructed to do so. If you have questions about disposing of your medication, consult your pharmacist. You may also want to check if there are drug take-back programs in your area.

Missing a Dose

If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and resume your regular schedule. Do not take two doses at the same time or take extra doses to make up for the missed one.
💡

Lifestyle & Tips

  • Take the tablet whole; do not crush, chew, or divide it.
  • Take with food, preferably in the morning, to reduce stomach upset.
  • Avoid alcohol while taking this medication.
  • Do not stop taking this medication suddenly without talking to your doctor, as it can cause withdrawal symptoms.
  • Be aware that it may take several weeks to feel the full effects of the medication.
  • Report any new or worsening symptoms, especially changes in mood, behavior, or thoughts of self-harm, to your doctor immediately.
  • Use caution when driving or operating machinery until you know how this medication affects you, as it may cause dizziness or drowsiness.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Varies by indication. For Major Depressive Disorder (MDD): 25 mg once daily in the morning. For Panic Disorder: 12.5 mg once daily in the morning. For Premenstrual Dysphoric Disorder (PMDD): 12.5 mg once daily.
Dose Range: 12.5 - 75 mg

Condition-Specific Dosing:

Major Depressive Disorder (MDD): Initial 25 mg once daily; may increase by 12.5 mg/day at weekly intervals to a maximum of 62.5 mg/day.
Panic Disorder: Initial 12.5 mg once daily; may increase by 12.5 mg/day at weekly intervals to a maximum of 75 mg/day.
Premenstrual Dysphoric Disorder (PMDD): Initial 12.5 mg once daily; may increase to 25 mg once daily. Can be administered daily throughout the menstrual cycle or during the luteal phase only.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established (Safety and efficacy not established; use generally not recommended due to Black Box Warning regarding suicidality)
Adolescent: Not established (Safety and efficacy not established; use generally not recommended due to Black Box Warning regarding suicidality)
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No specific adjustment needed for mild impairment (CrCl > 60 mL/min).
Moderate: Initial dose should be at the lower end of the dosing range (e.g., 12.5 mg/day for MDD or Panic Disorder). Max dose should not exceed 50% of the usual recommended dose.
Severe: Initial dose should be at the lower end of the dosing range (e.g., 12.5 mg/day for MDD or Panic Disorder). Max dose should not exceed 50% of the usual recommended dose.
Dialysis: Considerations: Paroxetine is highly protein-bound and not significantly removed by dialysis. Dose adjustment as per severe renal impairment.

Hepatic Impairment:

Mild: Initial dose should be at the lower end of the dosing range (e.g., 12.5 mg/day for MDD or Panic Disorder). Max dose should not exceed 50% of the usual recommended dose.
Moderate: Initial dose should be at the lower end of the dosing range (e.g., 12.5 mg/day for MDD or Panic Disorder). Max dose should not exceed 50% of the usual recommended dose.
Severe: Initial dose should be at the lower end of the dosing range (e.g., 12.5 mg/day for MDD or Panic Disorder). Max dose should not exceed 50% of the usual recommended dose.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Paroxetine is a potent and selective inhibitor of serotonin (5-hydroxytryptamine; 5-HT) reuptake in the central nervous system (CNS). It has weak effects on norepinephrine and dopamine neuronal reuptake. The antidepressant and anxiolytic effects are presumed to be related to its potentiation of serotonergic activity in the CNS resulting from this inhibition.
📊

Pharmacokinetics

Absorption:

Bioavailability: Approximately 50-60% (variable due to first-pass metabolism)
Tmax: 6-10 hours (for controlled-release formulation)
FoodEffect: Food does not significantly affect the bioavailability of paroxetine CR, but it may slightly delay Tmax. It is recommended to take with food to minimize GI upset.

Distribution:

Vd: Approximately 9.8 L/kg
ProteinBinding: Approximately 95% (primarily to plasma proteins)
CnssPenetration: Yes

Elimination:

HalfLife: Approximately 21 hours (range 10-24 hours, can be longer in some individuals)
Clearance: Highly variable due to saturable first-pass metabolism
ExcretionRoute: Approximately 64% via urine (2% as unchanged drug, 62% as metabolites); approximately 36% via feces (primarily as metabolites)
Unchanged: Approximately 2% (in urine)
âąī¸

Pharmacodynamics

OnsetOfAction: Initial therapeutic effects may be seen within 1-2 weeks, but full antidepressant effects may take 4-6 weeks.
PeakEffect: Typically 4-6 weeks for full therapeutic effect.
DurationOfAction: Due to its half-life, effects persist for approximately 24 hours, allowing for once-daily dosing. Discontinuation syndrome can occur rapidly upon abrupt cessation.

Safety & Warnings

âš ī¸

BLACK BOX WARNING

Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of Major Depressive Disorder (MDD) and other psychiatric disorders. Anyone considering the use of Paxil CR or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults older than 24 years; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 years and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber.
âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor immediately or seek emergency medical attention:

Signs of an allergic reaction: rash, hives, itching, redness, swelling, blistering, or peeling skin (with or without fever), wheezing, tightness in the chest or throat, difficulty breathing, swallowing, or speaking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat.
Signs of low sodium levels: headache, difficulty focusing, memory problems, confusion, weakness, seizures, or changes in balance.
Signs of infection: fever, chills, severe sore throat, ear or sinus pain, cough, increased or discolored sputum, painful urination, mouth sores, or a wound that won't heal.
Signs of bleeding: vomiting or coughing up blood, coffee ground-like vomit, blood in the urine, black, red, or tarry stools, gum bleeding, abnormal vaginal bleeding, unexplained bruises or bruising that worsens, or uncontrollable bleeding.
Severe dizziness or fainting.
Bone pain.
Seizures.
Significant weight loss.
Abnormal burning, numbness, or tingling sensations.
Painful or prolonged erections (lasting more than 4 hours).
Sexual problems, including decreased libido, difficulty achieving orgasm, ejaculation issues, or erectile dysfunction. If you have concerns, discuss them with your doctor.

Serotonin Syndrome: A Potentially Life-Threatening Condition

There is a risk of developing serotonin syndrome, a severe and potentially deadly condition, especially when taking certain other medications. Seek immediate medical attention if you experience:

Agitation
Balance problems
Confusion
Hallucinations
Fever
Rapid or irregular heartbeat
Flushing
Muscle twitching or stiffness
Seizures
Shivering or shaking
Excessive sweating
Severe diarrhea, nausea, or vomiting
Severe headache

Other Possible Side Effects

Most medications can cause side effects, but many people experience none or only mild symptoms. If you notice any of the following side effects or any other unusual symptoms, contact your doctor or seek medical attention if they bother you or persist:

Dizziness, drowsiness, fatigue, or weakness
Nervousness or excitability
Headache
Constipation, diarrhea, stomach pain, nausea, vomiting, or decreased appetite
Gas
Dry mouth
Sleep disturbances
Shakiness
Yawning
Back pain
* Sweating

Reporting Side Effects

This list is not exhaustive, and you may experience other side effects. If you have questions or concerns, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Worsening depression or anxiety
  • Thoughts of harming yourself or others
  • Unusual changes in behavior (e.g., agitation, restlessness, irritability, aggression, impulsivity)
  • Panic attacks
  • Difficulty sleeping (insomnia)
  • Extreme excitement or energy (mania/hypomania)
  • Confusion, hallucinations, rapid heart rate, sweating, muscle stiffness, twitching, or severe nausea/vomiting/diarrhea (signs of Serotonin Syndrome)
  • Unusual bleeding or bruising
  • Severe skin rash or allergic reaction
  • Seizures
  • Symptoms of low sodium (headache, confusion, weakness, unsteadiness, falls)
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced.
If you have been diagnosed with narrow-angle glaucoma.
If you are currently taking or have recently taken any of the following medications: Linezolid, methylene blue, pimozide, or thioridazine.
If you have taken any medications for depression or Parkinson's disease within the last 14 days, including isocarboxazid, phenelzine, tranylcypromine, selegiline, or rasagiline, as this may increase the risk of very high blood pressure.

Please note that this is not an exhaustive list of all potential interactions. To ensure your safety, it is crucial to inform your doctor and pharmacist about all the medications you are taking, including:

Prescription and over-the-counter (OTC) medications
Natural products
* Vitamins

Additionally, share any health problems you have with your doctor. It is vital to verify that it is safe to take this medication with all your other medications and health conditions. Do not start, stop, or change the dose of any medication without first consulting your doctor.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Before engaging in activities that require alertness, such as driving, wait until you understand how this drug affects you.

To minimize the risk of side effects, do not abruptly stop taking this medication without consulting your doctor. If you need to discontinue use, your doctor will guide you on how to gradually taper off the drug.

While taking this medication, avoid consuming alcohol and consult your doctor before using marijuana, cannabis, or prescription and over-the-counter drugs that may impair your reactions.

It may take several weeks to experience the full effects of this medication. Be aware that it may increase the risk of fractures; discuss this with your doctor.

Additionally, this medication may elevate the risk of bleeding, which can be life-threatening in some cases. Consult your doctor about this potential risk.

Some individuals may be more prone to eye problems while taking this medication. Your doctor may recommend an eye exam to assess your risk. If you experience eye pain, changes in vision, or swelling and redness around the eye, contact your doctor immediately.

This medication can cause low sodium levels, which can be life-threatening and lead to seizures, loss of consciousness, breathing difficulties, or death. If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects.

In children and adolescents, this medication may affect growth in some cases. Regular growth checks may be necessary; discuss this with your doctor.

This medication's impact on fertility is unknown, and it is unclear if any effects on fertility will be reversible.

If you are pregnant, plan to become pregnant, or are breastfeeding, inform your doctor. Taking this medication during the first trimester may increase the risk of birth defects, primarily heart defects, in the unborn baby. Using this medication during the third trimester may increase the risk of postpartum bleeding and potentially cause health problems in the newborn. Your doctor will help you weigh the benefits and risks of taking this medication during pregnancy and breastfeeding.
🆘

Overdose Information

Overdose Symptoms:

  • Drowsiness
  • Nausea
  • Vomiting
  • Tachycardia (fast heart rate)
  • Tremor
  • Agitation
  • Dizziness
  • Dilated pupils
  • Serotonin syndrome (severe cases)
  • Coma (rare, in very large overdoses or with co-ingestants)

What to Do:

Seek immediate medical attention. Call 911 or Poison Control at 1-800-222-1222. Treatment is generally supportive, including maintaining an open airway, monitoring cardiac and vital signs. Activated charcoal may be considered if ingested recently. There is no specific antidote.

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Monoamine Oxidase Inhibitors (MAOIs) (e.g., phenelzine, selegiline, linezolid, methylene blue): Risk of serotonin syndrome. Must wait at least 14 days after discontinuing MAOI before starting paroxetine, and at least 14 days after discontinuing paroxetine before starting an MAOI.
  • Pimozide: Increased pimozide levels and QT prolongation.
  • Thioridazine: Increased thioridazine levels and risk of serious ventricular arrhythmias and sudden death.
🔴

Major Interactions

  • Triptans (e.g., sumatriptan, zolmitriptan): Risk of serotonin syndrome.
  • Other serotonergic drugs (e.g., tramadol, fentanyl, lithium, St. John's Wort, tryptophan, other SSRIs/SNRIs, tricyclic antidepressants): Risk of serotonin syndrome.
  • Warfarin and other oral anticoagulants: Increased risk of bleeding due to paroxetine's effect on platelet aggregation.
  • NSAIDs and aspirin: Increased risk of bleeding.
  • Drugs metabolized by CYP2D6 (e.g., metoprolol, flecainide, propafenone, atomoxetine, risperidone, desipramine): Paroxetine is a potent CYP2D6 inhibitor, leading to increased levels of these drugs.
  • Tamoxifen: Paroxetine can significantly reduce the effectiveness of tamoxifen by inhibiting its conversion to active metabolites via CYP2D6.
🟡

Moderate Interactions

  • Cimetidine: May increase paroxetine levels.
  • Phenobarbital, Phenytoin: May decrease paroxetine levels.
  • Fosamprenavir/Ritonavir: May decrease paroxetine levels.
  • Theophylline: Paroxetine may increase theophylline levels.
  • Digoxin: Paroxetine may increase digoxin levels.
  • Alcohol: Concomitant use is not recommended due to potential for additive CNS effects.
đŸŸĸ

Minor Interactions

  • Not available (most interactions are considered moderate to major due to paroxetine's potent CYP2D6 inhibition and serotonergic effects)

Monitoring

đŸ”Ŧ

Baseline Monitoring

Psychiatric evaluation (mood, anxiety, suicidal ideation)

Rationale: To establish baseline symptom severity and identify risk factors for suicidality.

Timing: Prior to initiation

Complete Blood Count (CBC)

Rationale: To assess for baseline hematologic abnormalities, though not a direct effect of paroxetine, it's good practice.

Timing: Prior to initiation

Electrolytes (especially Sodium)

Rationale: To establish baseline, as hyponatremia (SIADH) can occur, particularly in elderly or those on diuretics.

Timing: Prior to initiation

Renal and Hepatic Function Tests

Rationale: To guide initial dosing adjustments in patients with impairment.

Timing: Prior to initiation

Weight and Height (BMI)

Rationale: To establish baseline, as weight changes can occur.

Timing: Prior to initiation

📊

Routine Monitoring

Clinical response and symptom severity (e.g., HAM-D, GAD-7, PHQ-9 scores)

Frequency: Weekly for first 4-6 weeks, then monthly or as clinically indicated

Target: Reduction in symptom scores, remission of symptoms

Action Threshold: Lack of improvement after 4-6 weeks, worsening symptoms, or emergence of new symptoms (especially suicidality) warrants re-evaluation.

Suicidal ideation and behavior

Frequency: Weekly for first 4 weeks, then every 2 weeks for next 4 weeks, then monthly for 3 months, then periodically as clinically indicated (especially in pediatric, adolescent, and young adult patients)

Target: Absence of suicidal thoughts or plans

Action Threshold: Any new or worsening suicidal thoughts, attempts, or plans require immediate clinical intervention.

Adverse effects (e.g., GI upset, sexual dysfunction, insomnia, agitation)

Frequency: At each visit, especially during dose titration

Target: Tolerable side effect profile

Action Threshold: Intolerable side effects may require dose adjustment or change in therapy.

Electrolytes (Sodium)

Frequency: Periodically, especially in elderly, those on diuretics, or with symptoms of hyponatremia.

Target: 135-145 mEq/L

Action Threshold: Sodium < 135 mEq/L, especially with symptoms, requires investigation and potential intervention.

Weight

Frequency: Every 3-6 months or as clinically indicated

Target: Stable weight or within acceptable range

Action Threshold: Significant weight gain or loss may require intervention.

Blood Pressure and Heart Rate

Frequency: Periodically, especially in patients with cardiovascular risk factors.

Target: Within normal limits

Action Threshold: Significant changes may warrant investigation.

đŸ‘ī¸

Symptom Monitoring

  • Worsening depression
  • New or worsening anxiety
  • Agitation
  • Restlessness
  • Panic attacks
  • Insomnia
  • Irritability
  • Hostility
  • Aggressiveness
  • Impulsivity
  • Akathisia (psychomotor restlessness)
  • Hypomania or mania
  • Suicidal ideation or behavior
  • Symptoms of Serotonin Syndrome (agitation, hallucinations, delirium, tachycardia, labile blood pressure, hyperthermia, hyperreflexia, incoordination, nausea, vomiting, diarrhea)
  • Symptoms of hyponatremia (headache, difficulty concentrating, memory impairment, confusion, weakness, unsteadiness, falls, severe and more acute manifestations include hallucinations, syncope, seizure, coma, respiratory arrest)
  • Unusual bleeding or bruising

Special Patient Groups

🤰

Pregnancy

Category D. Paroxetine is associated with an increased risk of congenital cardiac malformations (e.g., atrial and ventricular septal defects) when exposed during the first trimester. Exposure in late pregnancy has been associated with persistent pulmonary hypertension of the newborn (PPHN) and neonatal withdrawal syndrome (e.g., respiratory distress, feeding difficulties, irritability, tremor). Use only if the potential benefit justifies the potential risk to the fetus.

Trimester-Specific Risks:

First Trimester: Increased risk of congenital cardiac malformations (e.g., VSD, ASD).
Second Trimester: Not specifically associated with unique risks beyond general SSRI exposure.
Third Trimester: Risk of persistent pulmonary hypertension of the newborn (PPHN) and neonatal withdrawal syndrome (poor feeding, irritability, respiratory distress, tremor, seizures).
🤱

Lactation

L3 (Moderate Risk). Paroxetine is excreted into breast milk. While levels in breast milk are generally low, some infants may experience adverse effects such as drowsiness, poor feeding, and weight loss. Monitor breastfed infants for adverse effects. Consider alternative antidepressants with lower infant exposure or risk, or weigh the benefits of breastfeeding against the potential risks.

Infant Risk: Low to moderate risk. Potential for drowsiness, irritability, poor feeding, and weight loss in breastfed infants. Long-term effects are unknown.
đŸ‘ļ

Pediatric Use

Safety and efficacy have not been established in pediatric patients. Antidepressants, including paroxetine, increase the risk of suicidal thinking and behavior in children, adolescents, and young adults (see Black Box Warning). Use is generally not recommended in this population.

👴

Geriatric Use

Use with caution. Elderly patients may be more sensitive to the effects of paroxetine, particularly hyponatremia (SIADH) and bleeding. A lower starting dose (e.g., 12.5 mg/day) and slower titration are recommended. Monitor closely for adverse effects and drug interactions.

Clinical Information

💎

Clinical Pearls

  • Paxil CR is a controlled-release formulation; it should not be crushed, chewed, or divided, as this can lead to rapid release of the drug and increased side effects.
  • Always counsel patients on the Black Box Warning regarding suicidality, especially in younger patients, and the importance of close monitoring.
  • Paroxetine is a potent CYP2D6 inhibitor, which is a significant source of drug interactions. Be mindful of co-prescribing with other CYP2D6 substrates (e.g., tamoxifen, metoprolol, atomoxetine) or drugs with narrow therapeutic indices.
  • Due to its relatively short half-life compared to some other SSRIs, paroxetine is associated with a higher incidence and severity of discontinuation syndrome if stopped abruptly. Taper slowly over several weeks when discontinuing.
  • Take with food to minimize gastrointestinal side effects.
  • Consider alternative SSRIs for pregnant or breastfeeding individuals due to the higher risks associated with paroxetine in these populations.
🔄

Alternative Therapies

  • Other Selective Serotonin Reuptake Inhibitors (SSRIs): Sertraline (Zoloft), Fluoxetine (Prozac), Escitalopram (Lexapro), Citalopram (Celexa), Fluvoxamine (Luvox)
  • Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs): Venlafaxine (Effexor), Duloxetine (Cymbalta), Desvenlafaxine (Pristiq)
  • Atypical Antidepressants: Bupropion (Wellbutrin), Mirtazapine (Remeron), Trazodone
  • Tricyclic Antidepressants (TCAs): Amitriptyline, Nortriptyline, Imipramine
  • Monoamine Oxidase Inhibitors (MAOIs): Phenelzine, Selegiline (rarely used due to significant interactions)
  • Psychotherapy (e.g., Cognitive Behavioral Therapy - CBT)
  • Electroconvulsive Therapy (ECT) for severe, refractory depression
💰

Cost & Coverage

Average Cost: $50 - $200 per 30 tablets (generic)
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (for generic)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor for further evaluation and guidance. To ensure safe and effective treatment, never share your medication with others or take someone else's medication.

This medication is accompanied by a Medication Guide, a patient fact sheet that provides crucial information. It is essential to read this guide carefully and review it again whenever your prescription is refilled. If you have any questions or concerns about this medication, consult your doctor, pharmacist, or other healthcare provider for clarification.

In the event of a suspected overdose, immediately contact your local poison control center or seek emergency medical attention. When reporting the incident, be prepared to provide detailed information, including the name of the medication taken, the amount consumed, and the time it occurred.